Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tabletsU.S. losartan ...
Scienture launches Arbli, the first FDA-approved liquid losartan, expanding hypertension treatment access across US ...
TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value ...
Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation. ・The U.S. losartan ...
COMMACK, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value ...
BEDMINSTER, N.J.--(BUSINESS WIRE)--Nautilus Neurosciences, Inc. has completed a transaction for the sale of the U.S. and Canadian rights to CAMBIA® (diclofenac potassium for oral solution) to Depomed, ...
Radiation fears from the shutdown of nuclear reactors in earthquake ravaged Japan has caused a run on potassium iodide and raised questions about the health effects of taking the substance. It also ...